Loading company…
Suzhou Sitikangchen develops diagnostic and therapeutic radiopharmaceuticals for oncology.
Founded in 2021 and based in Suzhou, China, Suzhou Sitikangchen develops precision nuclear medicine solutions for cancer screening, imaging and treatment. It works with hospitals, research institutions and oncology centers on diagnostic tools and radiopharmaceutical therapies. In September 2025, it closed venture funding from Langsheng Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in